Skip to content

SCHEDULE 13D/AAccepted Oct 29, 7:07 PM ET

Neumora Therapeutics, Inc. SCHEDULE 13D/A

ARCH Venture Fund XII, L.P.

Accepted (ET)

7:07 PM

Oct 29, 2025

Filed

Oct 29, 2025

Documents

1

Size

36.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.